VERRICA PHARMACEUTICALS INC revenue for the last year amounted to 4.64 M EUR, the most of which — 4.64 M EUR — came from its highest performing source at the moment, Novel Topical Solution of Cantharidin, the year earlier bringing 8.44 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought VERRICA PHARMACEUTICALS INC 4.64 M EUR, and the year before that — 8.44 M EUR.